
3.61BUSD
Type
Common Stock
Exchange
PINK
Currency Code
USD
Currency Name
US Dollar
Country Name
USA
Country ISO
US
ISIN
US04530Y1064
CUSIP
04530Y106
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
June
IPO date
-
Updated At
-
PE Ratio
-
PEG Ratio
-
Book Value
10.89
Dividend Share
2.11
Dividend Yield
1.50%
Earnings Share
-0.25
Wall Street Target Price
-
EPS Estimate Current Year
-
EPS Estimate Next Year
-
EPS Estimate Current Quarter
0
EPS Estimate Next Quarter
0
Most Recent Quarter
-
Revenue TTM
42,592,002,048
Gross Profit TTM
18,308,999,168
EBITDA
7,608,000,000
Profit Margin
-4.69%
Return On Assets TTM
2.85%
Return On Equity TTM
-2.17%
Revenue Per Share TTM
95.874
Qtly Revenue Growth YOY
-4.30%
Diluted Eps TTM
-0.25
Qtly Earnings Growth YOY
-38.40%
Trailing PE
0.00
Forward PE
5
Price Sales TTM
0.0849
Price Book MRQ
0.7342
Enterprise Value Revenue
2
Enterprise Value EBITDA
133
4.78
3.58%151.34
1.43%29.84
0.51%40.73
0.34%30.19
0.00%32.60
0.00%212.05
-6.90%34.07
-3.50%16.25
-2.49%82.01
-1.76%